You are here

Shared Decision-Making Could Affect Patients’ View of Fault, Liability

Involved Patients 80% Less Likely to Seek Legal Counsel

Shared decision-making can significantly lower the likelihood of patients filing lawsuits and complaints, according to a recent study in the Annals of Emergency Medicine.

Researchers enlisted 800 study participants, who were surveyed after completing decision-making vignettes for an appendicitis scenario.

Participants who engaged in shared decision-making were 80% less likely to want a lawyer than participants who did not engage in the decision-making. Regardless of whether the level of shared decision-making was cursory or intense, participants had more trust in their physicians, rated them more highly, and were less likely to blame them for an adverse outcome compared to participants who were not involved in any shared decision-making. 

The researchers say there are three main obstacles for clinicians when it comes to shared decision-making: finding the time to have conversations with patients; viewing shared decision-making as unsuitable because the options are not all prudent; and assuming that their patients don’t want to be involved in making decisions.

Often, although clinicians may select what they feel to be the best medical option for patients, they may not have considered the possible effects for a particular patient, particularly if his or her preferences are unknown.

Also, although clinicians often assume that some patients don’t want to be involved in shared decision-making, patients usually prefer to be involved when they understand the consequences.

Source: MedPageToday, January 27, 2019 

Recent Headlines

Potential contamination could lead to supply chain disruptions
Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs